Henning Søndergaard

Feb 1, 2024 | bmjopen.bmj.com | David C. Wheeler |Henning Søndergaard |Katarina Hedman |Cathy Gwynn

MethodsAPPETIZE (ClinicalTrials.gov identifier: NCT04566653) was a multicentre, non-interventional, exploratory, phase 4, single-blind, cross-sectional, randomised, cross-over study performed in 17 centres across the USA, Canada and a European Union (EU) region comprising France, Spain and Italy. Screening occurred at visit 1, within 7 days of visit 2 (tasting day), to gather baseline safety, laboratory and electrocardiogram (ECG) data, and to confirm that eligibility criteria were met.

Oct 25, 2023 | dovepress.com | Henning Søndergaard

Back to Journals » Patient Preference and Adherence » Volume 18 Authors Søndergaard H Received 25 October 2023 Accepted for publication 8 May 2024 Published 31 May 2024 Volume 2024:18 Pages 1059—1064 DOI https://doi.org/10.2147/PPA.S445399 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Johnny Chen Henning Søndergaard Danish Kidney Association, Taastrup, Denmark Correspondence: Henning Søndergaard, Danish Kidney...